More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.

Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...

Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...

GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...

The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...